Vir Biotechnology, Inc.
Hedge Funds Holdings
Last updated:
Vir Biotechnology, Inc.‘s stocks are currently a part of 196 hedge funds’ portfolios, which represents 57.9% of the total amount of its stocks outstanding. This makes up a total of 76.69M shares of Vir Biotechnology, Inc.. Compared to the previous quarter, the number fell by -10.35% or -8.85M shares fewer. As for the holding position changes, 42.86% (84) of current hedge fund investors increased the number of shares held, 26.02% (51) of current holders sold a part of the shares held, and 14.29% (28) closed the holdings completely. 35 hedge funds are new holders of Vir Biotechnology, Inc. stock in Q3 2022, it is 17.86% of total holders.
Hedge funds holding Vir Biotechnology (Q4 2019 – Q3 2022)
| Q4 2019 | 37 |
|---|---|
| Q1 2020 | 59 |
| Q2 2020 | 109 |
| Q3 2020 | 114 |
| Q4 2020 | 134 |
| Q1 2021 | 150 |
| Q2 2021 | 156 |
| Q3 2021 | 167 |
| Q4 2021 | 203 |
| Q1 2022 | 193 |
| Q2 2022 | 204 |
| Q3 2022 | 196 |
Hedge funds changes in Vir Biotechnology positions (Q4 2019 – Q3 2022)
| Q4 2019 | 37 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2020 | 29 | 15 | 9 | 7 | -1 |
| Q2 2020 | 61 | 37 | 4 | 10 | -3 |
| Q3 2020 | 33 | 48 | 21 | 27 | -15 |
| Q4 2020 | 40 | 54 | 24 | 20 | -4 |
| Q1 2021 | 38 | 37 | 63 | 22 | -10 |
| Q2 2021 | 35 | 66 | 32 | 28 | -5 |
| Q3 2021 | 37 | 62 | 45 | 25 | -2 |
| Q4 2021 | 58 | 75 | 55 | 21 | -6 |
| Q1 2022 | 45 | 82 | 40 | 51 | -25 |
| Q2 2022 | 52 | 74 | 54 | 41 | -17 |
| Q3 2022 | 35 | 84 | 51 | 28 | -2 |
Hedge funds changes in Vir Biotechnology stock options (Q4 2019 – Q3 2022)
| Q4 2019 | 0 | 0 |
|---|---|---|
| Q1 2020 | 699,000 | 342,000 |
| Q2 2020 | 9,936,000 | 10,218,000 |
| Q3 2020 | 5,685,000 | 5,600,000 |
| Q4 2020 | 10,928,000 | 14,265,000 |
| Q1 2021 | 34,505,000 | 42,241,000 |
| Q2 2021 | 29,303,000 | 20,597,000 |
| Q3 2021 | 27,139,000 | 14,283,000 |
| Q4 2021 | 35,321,000 | 38,182,000 |
| Q1 2022 | 16,733,000 | 10,325,000 |
| Q2 2022 | 11,559,000 | 6,656,000 |
| Q3 2022 | 3,869,000 | 3,806,000 |